Patient-level costs of staged unilateral versus immediate bilateral symmetrization mammoplasty in breast-conserving surgery | Zendy

Yasmin Grant | Zendy; Paul Thiruchelvam | Zendy; Lana Kovacevic | Zendy; Elías Mossialos | Zendy; Ragheed Al-Mufti | Zendy; Katy Hogben | Zendy; Dimitri Hadjiminas | Zendy; Daniel Leff | Zendy

Open Access

Patient-level costs of staged unilateral versus immediate bilateral symmetrization mammoplasty in breast-conserving surgery

Author(s) -

Yasmin Grant,

Paul Thiruchelvam,

Lana Kovacevic,

Elías Mossialos,

Ragheed Al-Mufti,

Katy Hogben,

Dimitri Hadjiminas,

Daniel Leff

Publication year - 2022

Publication title -

bjs open

Language(s) - English

Resource type - Journals

ISSN - 2474-9842

DOI - 10.1093/bjsopen/zrac073

Subject(s) - medicine , mammoplasty , interquartile range , surgery , breast cancer , augmentation mammoplasty , observational study , general surgery , cancer , implant , breast augmentation

Following therapeutic mammoplasty (TM), the contralateral breast may require a later balancing procedure to optimize shape and symmetry. The alternative is to offer patients simultaneous TM with immediate contralateral symmetrization via a dual-surgeon approach, with the goal of reducing costs and minimizing the number of subsequent hospital appointments in an era of COVID-19 surges. The aim of this cost-consequence analysis is to characterize the cost-benefit of immediate bilateral symmetrization dual-operator mammoplasty versus staged unilateral single operator for breast cancer surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research